• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Related letters  • Similar articles in this journal  Topic Collections  • Public Health  • Tobacco  • Drug Therapy  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

A. Paula Cupertino, PhD; Jo A. Wick, PhD; Kimber P. Richter, PhD; Laura Mussulman, MPH; Niaman Nazir, MBBS, MPH; Edward F. Ellerbeck, MPH, MD

Arch Intern Med. 2009;169(20):1928-1930.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Smoking cessation pharmacotherapy can double quit rates.¹ However, smokers often fail after a single quit attempt, and quitting smoking often involves multiple quit attempts over the course of months or years.^2-5 Few studies have tested the impact of providing repeated courses of pharmacotherapy to help smokers recover from relapses and engage in new cessation attempts.^6-11 As part of a study of chronic disease management for smoking cessation, we followed a cohort of smokers that was offered up to 4 courses of pharmacotherapy over 2 years. We examined their continued interest in using pharmacotherapy and the effect of that treatment.

Methods

Setting and Participants

We recruited smokers, regardless of their interest in quitting, from 50 rural primary care clinics throughout the state of Kansas.¹² Smokers were excluded if they were younger . . . [Full Text of this Article]

Intervention

Measurements and Follow-up

Statistical Analyses

Results

Comment

AUTHOR INFORMATION


CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

RELATED LETTERS

Use of Pharmacotherapy for Smoking Cessation in Italy
Arch Intern Med. 2009;169(20):1927-1928.
EXTRACT | FULL TEXT  

The Impact of Repeated Cycles of Pharmacotherapy on Smoking Cessation: A Longitudinal Cohort Study
A. Paula Cupertino, Jo A. Wick, Kimber P. Richter, Laura Mussulman, Niaman Nazir, and Edward F. Ellerbeck
Arch Intern Med. 2009;169(20):1928-1930.
EXTRACT | FULL TEXT  

Low-Carbohydrate Diet and Blood Lipid Levels: How Good and How Fast?
Dario Giugliano, Maria Ida Maiorino, and Katherine Esposito
Arch Intern Med. 2009;169(20):1930.
EXTRACT | FULL TEXT  

Low-Carbohydrate Diet and Blood Lipid Levels: How Good and How Fast?—Reply
David J. A. Jenkins, Julia M. W. Wong, and Cyril W. C. Kendall
Arch Intern Med. 2009;169(20):1930-1931.
EXTRACT | FULL TEXT  

The Case for Dual Renin-Angiotensin System Inhibition
Sheldon Hirsch
Arch Intern Med. 2009;169(20):1931.
EXTRACT | FULL TEXT  

The Case for Dual Renin-Angiotensin System Inhibition—Reply
Elaine Ku, Jeanie Park, Jay Vidhun, and Vito Campese
Arch Intern Med. 2009;169(20):1931.
EXTRACT | FULL TEXT  

Late-Life Social Activity
Saskia Verkleij, Jantine Scheele, and Johannes C. van der Wouden
Arch Intern Med. 2009;169(20):1931-1932.
EXTRACT | FULL TEXT  

Late-Life Social Activity—Reply
Aron S. Buchman, Patricia A. Boyle, Robert S. Wilson, Debra A. Fleischman, Sue E. Leurgans, and David A. Bennett
Arch Intern Med. 2009;169(20):1932.
EXTRACT | FULL TEXT